BD

Baburao Dandamudi

Active Director Managing Director DIN 00914395
DIN 00914395 First appointment Sep 1999 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Sep 1999
Shareholding value •••• Premium profile

About Baburao Dandamudi

Data last updated:

Baburao Dandamudi is a Managing Director at Sionc Pharmaceuticals Private Limited (since 2008), Managing Director at Susi Sea Foods Private Limited (since 1999) and Director at Sionc Laboratories Private Limited (since 2021). The companies operate in Pharma, Agriculture and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹148 Cr; the largest is Sionc Pharmaceuticals Private Limited at ₹148 Cr (FY 2024). Earlier, Baburao Dandamudi was a Director at Arya Sea Foods Private Limited (2021–2022) and Director at Sintezon Labs Private Limited (from 2015).

DIN 00914395
Primary Designation Managing Director
Industry Pharma
First Appointment 14 Sep 1999
Oldest Company Age 40 yrs
Largest company Sionc Pharmaceuticals Private Limited · ₹148 Cr (FY 2024)
Combined revenue ₹148 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director01 Feb 20082008₹148 Cr (FY 2024)Active
Susi Sea Foods Private Limited U05001AP1985PTC005930
Managing Director14 Sep 19991985₹2.6 Lakh (FY 2020)Active
Sionc Laboratories Private Limited U24299AP2021PTC117064
Director11 Jan 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arya Sea Foods Private Limited U05004AP2014PTC095097
Director06 Apr 20212014₹99.03 Cr (FY 2025)Active
Sintezon Labs Private Limited U74900AP2015PTC097102
Director04 Aug 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Susi Sea Foods Private Limited
Sionc Pharmaceuticals Private Limited
Sionc Laboratories Private Limited
Sintezon Labs Private Limited
Premium access

Shareholding and investment profile for Baburao Dandamudi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Baburao Dandamudi

Baburao Dandamudi currently holds 3 directorships: Sionc Pharmaceuticals Private Limited (Managing Director, since 01 Feb 2008, revenue ₹148 Cr (FY 2024)); Susi Sea Foods Private Limited (Managing Director, since 14 Sep 1999, revenue ₹2.6 Lakh (FY 2020)); Sionc Laboratories Private Limited (Director, since 11 Jan 2021).

Baburao Dandamudi was first appointed on 14 Sep 1999 as Managing Director at Susi Sea Foods Private Limited. The most recent appointment on record is 06 Apr 2021 at Arya Sea Foods Private Limited.

The 2 current companies of Baburao Dandamudi that report revenue have a combined latest revenue of ₹148 Cr: Sionc Pharmaceuticals Private Limited ₹148 Cr (FY 2024); Susi Sea Foods Private Limited ₹2.6 Lakh (FY 2020).

Baburao Dandamudi held 2 earlier board appointments: Arya Sea Foods Private Limited (Director, 06 Apr 2021 to 14 Dec 2022); Sintezon Labs Private Limited (Director, from 04 Aug 2015).

The current boards of Baburao Dandamudi's companies include Jagadeesh Babu Rangisetty (Sionc Pharmaceuticals Private Limited), Manikreddy Pullagurla (Sionc Pharmaceuticals Private Limited), Srikanth Dandamudi (Sionc Pharmaceuticals Private Limited), Subba Rao Jetti (Sionc Pharmaceuticals Private Limited), Suman Lahoti (Sionc Pharmaceuticals Private Limited), Jyothi Dandamudi (Susi Sea Foods Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available